Sarah Reiter Net Worth & Insider Trades
Sarah Reiter - Chief Commercial Officer, Arcadia Biosciences, Inc
What is Sarah Reiter's Net Worth?
The current estimated net worth of Arcadia Biosciences, Inc's Chief Commercial Officer, Sarah Reiter, is estimated to be about $19.2K . Sarah Reiter owns about 3,800 units of Arcadia Biosciences, Inc common stock. In the last 2 years at Arcadia Biosciences, Inc, Sarah Reiter has sold an estimated value of $0 worth.
What is Sarah Reiter's Past Insider Trading?
Sarah Reiter's largest purchase order was 1,200 units , worth over $7.78K on September 10, 2019. In total, Sarah Reiter has made about 7 transactions over 2 years of their time at Arcadia Biosciences, Inc. Sarah Reiter usually trades in September, with the busiest year in 2019. The most recent transaction was a purchase order of 700 units , worth over $1.2K on February 4, 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sarah Reiter
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Sarah Reiter's Salary in 2020?
As Chief Commercial Officer of Arcadia Biosciences, Inc, Sarah Reiter has a total base salary of $210,972 . Sarah Reiter received compensation valued at about $527,155 in 2020 after becoming Chief Commercial Officer. The vast majority of their compensation came in the form of option awards of $214,241 , other compensation of $101,942 .
What is Sarah Reiter's' Mailing Address?
- Mailing address is 202 Cousteau Place Davis CA 95618 CA
Arcadia Biosciences, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Matthew T. Plavan | 2020 | $370,000 | - | - | $325,642 | $98,506 | - | $794,148 |
| Matthew T. Plavan | 2019 | $321,538 | - | - | $105,040 | $154,500 | - | $581,078 |
| Pamela Haley | 2020 | $240,000 | - | - | $171,391 | $31,800 | - | $443,191 |
| Pamela Haley | 2019 | $212,671 | - | - | $16,564 | $55,800 | - | $285,035 |
| Randall Shultz | 2020 | $244,923 | $12,500 | - | $158,157 | $15,900 | - | $431,480 |
| Randall Shultz | 2019 | $160,096 | $12,500 | - | $85,500 | $39,200 | $42,268 | $339,564 |
| Sarah Reiter | 2020 | $210,972 | - | - | $214,241 | - | $101,942 | $527,155 |
| Sarah Reiter | 2019 | $268,840 | $12,500 | - | $94,152 | $80,900 | - | $456,392 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459021019590/rkda-def14a_20210602.htm
What are Arcadia Biosciences, Inc's Past Insider Trades?
Arcadia Biosciences, Inc's most recent insider trade came on August 7, 2023 by Thomas J Schaefer who bought 649 units worth $2.38K . In the last 8 years, insiders at Arcadia Biosciences, Inc have sold an estimated value of $1.76M and bought an estimated value of $23.27M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Eric Rey, Director, Kevin Comcowich, Director, and Matthew Plavan, Chief Executive Officer .
Arcadia Biosciences, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||